威尼托克拉克斯抑制慢性淋巴细胞白血病细胞的自
Yongqiang Chen, Sara E F Kost, Xiaoyan Yang1
1Department of Oncology, University of Alberta, Edmonton, Alberta, Canada.
Autophagy reports
|May 21, 2025
概括
威尼托克拉克斯 (VCX) 抑制了癌细胞生存的过程 - - 癌细胞生存的过程 - - 自. 这一发现揭示了VCX的新机制,并提出了针对白血病自的组合疗法.
科学领域:
- 分子生物学分子生物学
- 癌症研究 癌症研究
- 细胞生物学 细胞生物学
背景情况:
- 威尼托克拉克斯 (VCX) 是一种经批准的BCL2抑制剂,用于治疗像CLL这样的B细胞白血病.
- 已知VCX在亡中的作用,但其他机制需要澄清.
- 自是一种细胞降解过程,对癌细胞的生存和死亡至关重要.
研究的目的:
- 为了研究Venetoclax (VCX) 在自中的功能.
- 为了确定VCX是否调节自途径.
主要方法:
- 使用西方斑点和光显微镜测量了自流量.
- 评估了与自相关的蛋白ATG12的水平.
主要成果:
- 威尼托克拉克斯 (VCX) 被确定为一种新型的自抑制剂.
- VCX治疗降低了与自相关蛋白ATG12的水平.
- VCX使B细胞系和初级CLL细胞对由氨基酸饥饿或ibrutinib诱导的细胞死亡敏感.
结论:
- 威尼托克拉克斯 (VCX) 抑制了自并降低了ATG12水平.
- 这项研究为将VCX与向B细胞恶性瘤自的疗法相结合提供了理由.
- 向自可能会提高venetoclax在治疗白血病中的疗效.
相关概念视频
Delivery Pathways to the Lysosome
6.1K
Eukaryotic cells use different mechanisms to eliminate toxic waste obsolete and worn-out substances. Lysosomes play a pivotal role in this, and hence, these substances are carried to the lysosome from other parts of the cell and extracellular space through different pathways. The most elaborately studied pathways to the lysosome are the endocytic pathways.
Endocytosis
In endocytosis, the cell membrane takes up macromolecules and particles from the surrounding medium. Clathrin-mediated...
Endocytosis
In endocytosis, the cell membrane takes up macromolecules and particles from the surrounding medium. Clathrin-mediated...
6.1K
Autophagy
4.1K
Autophagy is a self-digesting process by which a cell protects itself from threats both within and outside the cell, ranging from abnormal proteins to invading bacteria. In this process, obsolete components of the cell and invading microbes are degraded by hydrolytic enzymes active in an acidic environment of the lysosomal lumen.
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
4.1K
Autophagic Cell Death
2.9K
Christian de Duve discovered “autophagy,” a process in which cellular components are engulfed by membrane-bound organelles called autophagosomes. The autophagosomes then fuse with lysosomes to digest the enclosed contents. Autophagy is generally activated in cells to prevent cell death. However, cell death is triggered when the damage is beyond repair.
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and...
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and...
2.9K
The Intrinsic Apoptotic Pathway
5.9K
Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
5.9K
Lysosomal Hydrolases
3.7K
Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
3.7K
Inhibition of Cdk Activity
4.6K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.6K


